rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Beyond Air, Inc.

XAIR · Nasdaq

Health CareMedical DevicesNot moving yet

XAIR stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 72.1% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$512K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
28 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$434KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months6
Sale orders, 12 months0
Buyers · sellers3 · 0
WhoDidSharesTraded
Yi-Chien Lin10% ownerbought2,607at $2.2113 Oct 2026filed 14 Oct 2026
Yi-Chien Lin10% ownerbought15,393at $2.801 Oct 2026filed 2 Oct 2026
Yi-Chien Lin10% ownerbought2,000at $2.7130 Sep 2026filed 2 Oct 2026
Yi-Chien Lin10% ownerbought3,000at $2.6929 Sep 2026filed 2 Oct 2026
Daniel J. MoorheadChief Financial Officerbought4,340at $5.7629 Jul 2026filed 31 Jul 2026
Daniel J. MoorheadChief Financial Officerbought4,34029 Jul 2026filed 31 Jul 2026
Daniel J. MoorheadChief Financial Officerbought4,34029 Jul 2026filed 31 Jul 2026
Robert Scott GoodmanChief Executive Officerbought34,722at $5.7629 Jul 2026filed 31 Jul 2026
Robert Scott GoodmanChief Executive Officerbought34,72229 Jul 2026filed 31 Jul 2026
Robert Scott GoodmanChief Executive Officerbought34,72229 Jul 2026filed 31 Jul 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders28+2 on the quarter
New · exited6 · 4
Reported value$598K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Balyasny Asset Management L.P.unchanged · filed 14 Aug 2026464,161$207K00.0%
Murchinson Ltd.reduced · filed 14 Aug 2026274,208$122K-55,779−16.9%
Daytona Street Capital LLCreduced · filed 3 Aug 2026151,550$61K-5,300−3.4%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026112,242$50K-47,201−29.6%
Bleichroeder LPunchanged · filed 13 Aug 202686,489$39K00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 202662,741$28K+30,800+96.4%
COMMONWEALTH EQUITY SERVICES, LLCnew · filed 29 Jul 202647,382$21K+47,382
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202629,368$13K00.0%
BlackRock, Inc.unchanged · filed 7 Aug 202622,033$9,82500.0%
StoneX Group Inc.new · filed 12 Aug 202621,559$9,971+21,559
31 Mar 2023 – 30 Jun 2026
274461Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Yi-Chien Lin Company insider10% owner · last 13 Oct 20264 · 0
Daniel J. Moorhead Company insiderChief Financial Officer · last 29 Jul 20261 · 0
Robert Scott Goodman Company insiderChief Executive Officer · last 29 Jul 20261 · 0
Douglas Quinton Larson Company insiderChief Financial Officer · last 4 Nov 20250 · 0
Erick Lucera Company insiderDirector · last 4 Nov 20252 · 0
Michael A. Gaul Company insiderChief Operating Officer · last 4 Nov 20256 · 0
Robert Carey Company insiderDirector · last 4 Nov 202534 · 0
Steven A. Lisi Company insiderCEO and Chairman of the Board · last 4 Nov 202522 · 4
William P. Forbes Company insiderDirector · last 4 Nov 20253 · 0
Yoori Lee Company insiderDirector · last 4 Nov 20252 · 0
Ron Bentsur Company insiderDirector · last 22 Nov 20241 · 26
Amir Avniel Company insiderChief Business Officer · last 20 Mar 20243 · 25

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 31 Mar 20263.3%
Operating profit marginFY 2026 · to 31 Mar 2026-378%
Free cash flow marginFY 2026 · to 31 Mar 2026-250%
Return on capital employedFY 2026 · to 31 Mar 2026-101%
Research spendFY 2026 · to 31 Mar 2026133%
Share count trendFY 2026 · to 23 Jun 202622.2%
Cash and equivalentsFY 2026 · to 31 Mar 2026$6.7M
Free cash flowFY 2026 · to 31 Mar 2026−$19.2M

Analyst forecasts

No analyst forecasts yet.